គេហទំព័រព័ត៌មានកម្ពុជា

ISTANBUL, Turkiye, August 1, 2025 – (JCN Newswire via SeaPRwire.com) – Honda Turkiye A.S. (HTR) has decided to establish a new motorcycle factory in Aliaga, izmir, aimed at supporting growth in the motorcycle market and boosting global motorcycle sales.The COVID-19 pandemic has led to an increased demand for personal transportation and commercial use, such as delivery services, driving significant growth in the Turkish motorcycle market. As a result, Honda Turkiye set a new sales record in 2024 with annual sales reaching 162,000 motorcycles.Production is scheduled to begin in mid-2026. Initially, the plant will operate with an annual capacity of 100,000 motorcycles, with plans to increase production capacity to 200,000 units in the future. The total investment amount for the facility including machinery and equipment is approximately 20 million USD. The plant is expected to create employment opportunities for around 300 people.With this new investment, Honda Turkiye aims to strengthen local production activit…

TOKYO, Japan, August 1, 2025 – (JCN Newswire via SeaPRwire.com) – Honda Motor Co., Ltd. (Honda) has started a demonstration project jointly with Tokuyama Corporation (Tokuyama) and Mitsubishi Corporation (MC), to operate a data center using by-product hydrogen and a stationary fuel cell (FC) power station designed to reuse FC systems from fuel cell electric vehicles (FCEVs). The companies today held an opening ceremony at the demonstration site located in Shunan City, Yamaguchi Prefecture, Japan. Honda FC power station to be used for this demonstration projectThe three companies have been discussing and preparing for the launch of the demonstration project since June 2023, when this project was proposed to and adopted by the New Energy and Industrial Technology Development Organization (NEDO) as one of the projects for the “Development of Technologies for Realizing a Hydrogen Society / Development of Technologies for Regional Hydrogen Utilization.”In this demonstration project, a stationary FC power station t…

KARIYA, JAPAN, August 1, 2025 – (JCN Newswire via SeaPRwire.com) – BluE Nexus Corporation (headquartered in Anjo, Aichi; Hidetoshi Uchiyama, president; hereinafter “BluE”), AISIN Corporation (headquartered in Kariya, Aichi; Moritaka Yoshida, president; hereinafter “AISIN”), and DENSO CORPORATION (headquartered in Kariya, Aichi; Shinnosuke Hayashi, president; hereinafter “DENSO”) are proud to announce that, the eAxle jointly developed by the three companies has been installed in Isuzu’s first battery electric vehicle (BEV) pickup, D-MAX EV, which went into production in April 2025.The newly installed product combines the newly developed eAxle front and rear with a full-time *4WD system, contributing to both the tough basic performance required for pickup trucks (durability/loading and towing performance/rugged road drivability) and the linear acceleration and low noise and vibration characteristic of BEVs. The BEV is a 4WD system with a low-noise and low-vibration engine.As D-MAX EVs are gradually expanded glo…

Kawasaki, Japan, August 1, 2025 – (JCN Newswire via SeaPRwire.com) – Fujitsu today announced that it has started research and development towards a superconducting quantum computer with a capacity exceeding 10,000 qubits. Construction is slated for completion in fiscal 2030.The new superconducting quantum computer will operate with 250 logical qubits and will utilize Fujitsu’s innovative “STAR architecture,” an early-stage fault-tolerant quantum computing (early-FTQC) architecture also developed by the company. Fujitsu aims to make practical quantum computing possible, particularly in areas like materials science where complex simulations can unlock ground breaking discoveries, and to this end will focus on advancing key scaling technologies across various technical domains.As part of this effort, Fujitsu has been selected as an implementing party for the “Research and Development Project of the Enhanced Infrastructures for Post-5G Information and Communication Systems” [1], publicly solicited by the NEDO (Ne…

TOKYO, July 31, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that the global revenue(pre-audit basis) of the anti-amyloid-beta protofibril antibody “LEQEMBI®” (generic name: lecanemab) was JPY 23.1 billion for the first quarter of fiscal year 2025 (April 1, 2025 – June 30, 2025). By major markets, revenue came to JPY 9.1 billion in the United States, JPY 5.5 billion in Japan, and JPY 7.7 billion in Chinadue to increasing demand and stock piling by distributors (estimated at JPY 5.3 billion) in response to the risk of tariffs. This information is being disclosed in conjunction with today’s announcement of the financial results for the second quarter of 2025 by Biogen Inc. (Headquarters: Cambridge, Massachusetts). Eisai’s financial results for the first quarter of fiscal year 2025, including details of LEQEMBI’s revenue, will be disclosed in Eisai’s financial disclosure scheduled for August 5, 2025.Eisai serves as the lead of lecanema…

Takamatsu, Kagawa, July 23, 2025 – (JCN Newswire via SeaPRwire.com) – Sharp reached an agreement with Aoi Electronics Co., Ltd. (Headquarters / Takamatsu City, Kagawa Prefecture, President & CEO / Kazuhiro Kinoshita; hereinafter “Aoi Electronics”) on the transfer of Sharp Mie Plant No.2 and part of the land at Sharp Mie Base.Under its asset-light initiative in devices business and to transfer its structure centering its Brand business, Sharp is promoting the utilization of underutilized and unused factories, as well as business development through collaboration with other companies. This agreement is part of such initiative and corresponds to the consideration of transferring the Mie Plant No.2 mentioned in the news release dated March 31, 2025.Through Sharp Display Technology Corporation, Sharp’s subsidiary in charge of small and medium size LCD business, Sharp will collaborate with Aoi Electronics on the early start-up of their production line in the factories they bought.*Property for Transfer(1) Sharp…

TOKYO, July 31, 2025 – (JCN Newswire via SeaPRwire.com) – TANAKA PRECIOUS METAL GROUP Co., Ltd. (Headquarters: Chuo-ku, Tokyo; Group CEO: Koichiro Tanaka) has decided to enter into a business partnership with JEPLAN, INC. (Headquarters: Kawasaki City, Kanagawa; Representative Director, President, and Chief Executive Officer: Masaki Takao; hereinafter “JEPLAN”) to reduce CO₂ emissions and promote the recycling organic materials in the precious metal recovery processes of TANAKA PRECIOUS METAL TECHNOLOGIES Co., Ltd., a company engaged in precious metals business.This initiative represents a collaboration between TANAKA, committed to advancing a circular economy in the precious metals field, and JEPLAN, which has been pursuing similar goals in the plastics field, with both companies aiming to achieve a decarbonized, circular society.TANAKA’s Initiatives Thus Far for Realizing a Circular SocietySince its founding in 1885, TANAKA has been a leader in the precious metals industry, actively engaged in recycling thes…

KARIYA, JAPAN, July 31, 2024 – (JCN Newswire via SeaPRwire.com) – DENSO, a leading mobility supplier, today announced global financial results for the first quarter, ending June 30, 2025, of its fiscal year, ending March 31, 2026:Consolidated revenue totaled 1,754.1 billion yen (US$11.7 billion), remaining consistent with the previous year.Consolidated operating profit totaled 107.2 billion yen (US$0.7 billion), an 11.1 percent decrease from the previous year.Consolidated profit attributable to owners of the parent company totaled 79.3 billion yen(US$0.5 billion), a 16.1 percent decrease from the previous year.“Revenue in the first quarter remained consistent with the previous year, driven by a strong increase in vehicle sales in Japan, despite a decline in revenue due to the impact of the strong yen.” said Yasushi Matsui, CFO, Executive Vice President and member of the Board of Directors of DENSO CORPORATION.“In this fiscal year, we forecast 7,200.0 billion yen (US$48.2 billion) in revenue and 675.0 billion …

TOKYO, Japan, July 31, 2025 – (JCN Newswire via SeaPRwire.com) –Honda Motor Co., Ltd. today launched a teaser page on its company website to share information on the all-new Prelude, which is scheduled to go on sale in September 2025.The all-new Prelude is a specialty sports model which represents the unrelenting Honda sports mindset, carrying forward the “joy of driving” into the electrified era, while also pursuing environmental performance and everyday usability.All-New Prelude Teaser Page: https://www.honda.co.jp/PRELUDE/new/All-new PreludeOverview of all-new PreludeGrand Concept: “Unlimited Glide” — Endless driving pleasure & Extraordinary experience —Inspired by the image of gliders soaring freely and boundlessly through the open sky, Honda developed the all-new Prelude under the grand concept of “Unlimited Glide,” striving for a vehicle that evokes the uplifting sensation of gliding gracefully through the air and extraordinary experience that people do not have in their everyday lives.Like a glider…

Developing dual-use UAVs for civil and defense applicationsAutomating the transport of heavy cargo with MHI’s multi-purpose medium-sized UAVAccelerating the transport of medications using a VTOL (vertical take-off and landing) UAV capable of flying long distances at high speedTOKYO, July 31, 2025 – (JCN Newswire via SeaPRwire.com) – Mitsubishi Heavy Industries, Ltd. (MHI) participated in a practical training exercise held on July 17 at the Japan Ground Self-Defense Force (JGSDF) Asaka Garrison (Nerima-ku, Tokyo), aimed at improving response capabilities in the event of an earthquake centered on the Tokyo metropolitan area. The training was conducted by the JGSDF Eastern Army in cooperation with local governments, with MHI joining at the request of the Japan UAS Industrial Development Association (JUIDA). MHI conducted training to transport relief supplies to isolated disaster victims using its medium-sized multirotor uncrewed aerial vehicle (hereinafter “medium-sized UAV”) currently being developed by its Com…

– Data Showed LEQEMBI Slowed Clinical Decline by 1.75 Points on CDR-SB at Four Years Compared to the Natural History of Alzheimer’s Disease- 56% of Patients with Low Tau Continued to Demonstrate Improved Cognitive and Daily Living Function at Four YearsTOKYO and CAMBRIDGE, Mass., July 31, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”)and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher,“Biogen”) announced today that the latest findings demonstrating the benefits of continuous treatment with lecanemab-irmb (U.S. brand name: LEQEMBI®), an anti-amyloid beta (AB) protofibril* antibody for the treatment of early Alzheimer’s disease (AD), were presented at the Alzheimer’s Association International Conference(AAIC) 2025, held in Toronto, Canada, and virtually. Only lecanemab fights AD in two ways – targeting both amyloid plaque and protofibrils*, which can impact tau downstream.Four Years of Lecanemab Therapy…

TOKYO and CAMBRIDGE, Mass., July 31, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”)and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher,“Biogen”) announced today that results on investigational maintenance therapy with subcutaneous autoinjector (SCAI) of lecanemab-irmb (U.S. brand name: LEQEMBI®), an anti-amyloid beta (AB) protofibril* antibody for the treatment of early Alzheimer’s disease (AD), were presented at the Alzheimer’s Association International Conference(AAIC) 2025, held in Toronto, and virtually. Only lecanemab fights AD in two ways—targeting both protofibrils and plaque, which can impact tau accumulation downstream.Importance of Ongoing Treatment and SC Development ProgramDue to the reaccumulation of AD biomarkers and return to placebo rate of decline after therapy is stopped1, Eisai is investigating a new lecanemab SC maintenance treatment option following 18 months of IV therapy so pati…